Clatterbridge Cancer Centre NHS Foundation Trust has received £919,901,851 from 1 department.
We currently have no contracts recorded for Clatterbridge Cancer Centre NHS Foundation Trust.
A breakdown of the top government departments that have purchased goods and services from Clatterbridge Cancer Centre NHS Foundation Trust, ordered by total spend.
£920 Million
A breakdown of the top government organisations that have purchased goods and services from Clatterbridge Cancer Centre NHS Foundation Trust, ordered by total spend. These may be more granular than departments.
£907 Million
£10.5 Million
£2.51 Million
A breakdown of the top Expense Areas within each organisation that has purchased goods and services from Clatterbridge Cancer Centre NHS Foundation Trust, ordered by total spend.
NHS England - £539 Million
NHS England - £219 Million
NHS England - £99.5 Million
NHS England - £29.8 Million
NHS England - £18.4 Million
A breakdown of the top Expense Types within each organisation that has purchased goods and services from Clatterbridge Cancer Centre NHS Foundation Trust, ordered by total spend.
NHS England - £846 Million
Department of Health and Social Care - £28.7 Million
NHS England - £26.7 Million
NHS England - £17.5 Million
Department of Health and Social Care - £8.78 Million
| Date | Buyer | Amount | Expense Area | Expense Type | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-09-25 | £41,533 | Science and Research | Research & development | ||||||||
| Experimental Cancer Medical Centres | |||||||||||
| 2025-09-25 | £30,000 | Science and Research | Research & development | ||||||||
| Research for patients benefit programme (RFPB) | |||||||||||
| 2025-09-15 | -£27,737 | Finance | Interest Receivable NCB Loan | ||||||||
| Interest Receivable NCB Loan | |||||||||||
| 2025-09-15 | -£2,729,000 | Finance | Dividends receivable on PDC | ||||||||
| Dividends receivable on PDC | |||||||||||
| 2025-09-15 | -£125,000 | Finance | Curr Part of Lns Repay Tfr from Invest (ST) NCB Loan | ||||||||
| Curr Part of Lns Repay Tfr from Invest (ST) NCB Loan | |||||||||||
| 2025-06-25 | £43,378 | Chief Scientific Adviser | Research & development | ||||||||
| Infrastructure equipment call | |||||||||||
| 2025-06-25 | £41,533 | Chief Scientific Adviser | Research & development | ||||||||
| Experimental Cancer Medical Centres | |||||||||||
| 2025-05-19 | -£500,000 | Finance | Curr Part of Lns Repay Tfr from Invest (ST) NCB Loan | ||||||||
| Curr Part of Lns Repay Tfr from Invest (ST) NCB Loan | |||||||||||
| 2025-05-19 | -£240,000 | Finance | Curr Part of Lns Repay Tfr from Invest (ST) NCB Loan | ||||||||
| Curr Part of Lns Repay Tfr from Invest (ST) NCB Loan | |||||||||||
| 2025-05-19 | -£138,370 | Finance | Interest Receivable NCB Loan | ||||||||
| Interest Receivable NCB Loan | |||||||||||
| 2025-05-19 | -£66,418 | Finance | Interest Receivable NCB Loan | ||||||||
| Interest Receivable NCB Loan | |||||||||||
| 2025-03-20 | £165,000 | Chief Scientific Adviser | Research & development | ||||||||
| Infrastructure equipment call | |||||||||||
| 2025-03-20 | £41,533 | Chief Scientific Adviser | Research & development | ||||||||
| Experimental Cancer Medical Centres | |||||||||||
| 2025-03-17 | -£125,000 | Finance | Curr Part of Lns Repay Tfr from Invest (ST) NCB Loan | ||||||||
| Curr Part of Lns Repay Tfr from Invest (ST) NCB Loan | |||||||||||
| 2025-03-17 | -£30,510 | Finance | Interest Receivable NCB Loan | ||||||||
| Interest Receivable NCB Loan | |||||||||||
| 2025-03-14 | -£2,451,000 | Finance | Dividends receivable on PDC | ||||||||
| Dividends receivable on PDC | |||||||||||
| 2025-03-10 | £34,000 | Finance | Additions NCB PDC | ||||||||
| Additions NCB PDC | |||||||||||
| 2025-03-10 | £130,000 | Finance | Additions NCB PDC | ||||||||
| Additions NCB PDC | |||||||||||
| 2024-12-31 | £25,752 | NHS England Central Programme Costs | Services from other NHS bodies | ||||||||
| 2024-12-31 | £33,857 | NHS England Central Programme Costs | Services from other NHS bodies | ||||||||
Showing 1 to 20 of 504 transactions
The most recent payment data we have available for Clatterbridge Cancer Centre NHS Foundation Trust is from September 2025. Government departments and public bodies typically publish their spending data on a monthly or quarterly basis.
Clatterbridge Cancer Centre NHS Foundation Trust's government income has decreased over time. In 2025, they received -£5,906,056, compared to £147,144,377 in 2024 - a decrease of 104.0%.
Clatterbridge Cancer Centre NHS Foundation Trust has received a total of £919,901,851 from UK government organizations according to our records. This income comes from 3 government buyers.
The primary government buyer from Clatterbridge Cancer Centre NHS Foundation Trust is Department of Health and Social Care, which has spent £919,901,851.